Related Experiment Video

Updated: May 16, 2026

Isolation of Atrial Myocytes from Adult Mice
08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

The natriuretic peptides as biomarkers for adults with congenital heart disease

Amiram Nir1, Andreas Luchner, Azaria Jjt Rein

  • 1Department of Pediatric Cardiology, Hadassah Hebrew University Medical Center, POB 12000, Jerusalem 91120, Israel. amiramn@ekmd.huji.ac.il

Biomarkers in Medicine
|December 12, 2012
PubMed

Insights

Adults with congenital heart disease are a growing population. This review explores natriuretic peptides, key heart disease markers, in adults with congenital heart conditions.

Area of Science:

  • Cardiology
  • Biomarkers
  • Adult Congenital Heart Disease

Background:

  • Improved treatments have increased the adult congenital heart disease (ACHD) population.
  • ACHD patients present complex cardiac conditions and post-intervention sequelae.
  • Natriuretic peptides are established prognostic markers in acquired heart disease.

Purpose of the Study:

  • To review current knowledge on natriuretic peptides in adults with congenital heart disease.
  • To highlight the role of natriuretic peptides in ACHD management and prognosis.

Main Methods:

  • Literature review of studies on natriuretic peptides in ACHD.
  • Synthesis of existing data on natriuretic peptide levels and clinical correlation in ACHD.

Main Results:

  • Natriuretic peptides reflect disease severity and prognosis in ACHD.
  • Specific patterns of natriuretic peptides are observed across different congenital heart defects.
  • Natriuretic peptides aid in risk stratification and monitoring of ACHD patients.

Conclusions:

  • Natriuretic peptides are valuable biomarkers for adults with congenital heart disease.
  • Further research is needed to fully integrate natriuretic peptides into ACHD clinical practice.
  • Understanding natriuretic peptide roles can improve long-term outcomes for ACHD survivors.

More Related Videos

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...